These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 5160871)

  • 1. [Effectiveness of new lipotropic preparations in hyperlipemia].
    Miasnikov LA; Bavina MV; Lobova NM; Koropova GI
    Kardiologiia; 1971 Aug; 11(8):26-30. PubMed ID: 5160871
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypolipemic effect of diosponine in ischemic heart disease depending on the type of hyperlipoproteinemia].
    Zakharov VN
    Kardiologiia; 1977 Jun; 17(6):136-7. PubMed ID: 197285
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug treatment of hyperlipemia in middle-aged and old persons with ischemic heart disease].
    Semavin IE; Goliakov VN; Solov'ev VV
    Kardiologiia; 1977 Mar; 17(3):77-83. PubMed ID: 196132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The importance of determining the type of hyperlipidemia for lipotropic therapy of atherosclerosis].
    Bavina MV; Perova NV; Lobova NM; Koropova GI
    Kardiologiia; 1973 Mar; 13(3):27-33. PubMed ID: 4717180
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of halofenate on serum lipids.
    Aronow WS; Harding PR; Khursheed M; Vangrow JS; Papageorge's NP; Mays J
    Clin Pharmacol Ther; 1973; 14(3):358-65. PubMed ID: 4572798
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical evaluation of tibric acid (CP 18,524) a new hypolipidemic agent.
    Sirtori CR; Zoppi S; Quarisa B; Agradi E
    Pharmacol Res Commun; 1974 Oct; 6(5):445-56. PubMed ID: 4617230
    [No Abstract]   [Full Text] [Related]  

  • 7. Currently available lipid-lowering agents.
    Levy RI
    Hosp Pract (Off Ed); 1988 Jun; 23 Suppl 1():14-21. PubMed ID: 3134381
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperlipemia-improving effects of ginsenoside-Rb2 in streptozotocin-diabetic rats.
    Yokozawa T; Kobayashi T; Oura H; Kawashima Y
    Chem Pharm Bull (Tokyo); 1985 Sep; 33(9):3893-8. PubMed ID: 4092288
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fibrates: mechanism of action, effect on levels of lipids and risk of coronary events. II. Fenofibrate].
    Dobordzhginidze LM
    Kardiologiia; 2004; 44(3):87-93. PubMed ID: 15489838
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of essential hyperlipidemia with procetofene. Apropos of 100 cases].
    Fromantin M; Gautier D; Bon R
    Sem Hop Ther; 1977; 53(5-6):311-6. PubMed ID: 897691
    [No Abstract]   [Full Text] [Related]  

  • 11. [Behavior of the biological aging index and serum lipids in treatment with X50].
    Reuter W; Sauer I; Herrmann W
    Z Alternsforsch; 1986; 41(2):91-4. PubMed ID: 3754998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updating a 12-year experience with arrest and reversal therapy for coronary heart disease (an overdue requiem for palliative cardiology).
    Esselstyn CB
    Am J Cardiol; 1999 Aug; 84(3):339-41, A8. PubMed ID: 10496449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical drug therapy for common hyperlipidaemias.
    Tikkanen MJ
    Baillieres Clin Endocrinol Metab; 1990 Dec; 4(4):719-42. PubMed ID: 2082904
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of hypercholesterolaemia with colestipol: a bile sequestrating agent.
    Nye ER; Jackson D; Hunter JD
    N Z Med J; 1972 Jul; 76(482):12-6. PubMed ID: 4344110
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of CH 13.437 in different types of hyperlipidemia.
    Harvengt C
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:298+. PubMed ID: 4559547
    [No Abstract]   [Full Text] [Related]  

  • 16. [Overviews of fibrate].
    Tada N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():609-17. PubMed ID: 11347141
    [No Abstract]   [Full Text] [Related]  

  • 17. [Efficacy and safety of simvastatin in patients with hypercholesterolemia (results of a Multicenter Clinical Study)].
    Kukharchuk VV; Bubnova MG; Katel'nitskaia LI; Nikitin IuP; Ol'binskaia LI;
    Kardiologiia; 2003; 43(5):42-7. PubMed ID: 12891239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemfibrozil therapy in primary hypertriglyceridemia associated with coronary heart disease. Effects on metabolism of low-density lipoproteins.
    Vega GL; Grundy SM
    JAMA; 1985 Apr; 253(16):2398-403. PubMed ID: 3856692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypolipaemic drugs and coronary heart disease.
    Howard AN
    J Clin Pathol Suppl (R Coll Pathol); 1975; 9():106-14. PubMed ID: 783209
    [No Abstract]   [Full Text] [Related]  

  • 20. Dietary and pharmacologic therapy for the lipid risk factors.
    JAMA; 1983 Oct; 250(14):1873-9. PubMed ID: 6620484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.